Evaluation of postoperative residual curarization: a prospective clinical study

Background: Reversal of neuroblockade in general anesthesia is important to prevent possible complications. Currently, neostigmine and sugamedex are the agents of choice. The reversibility of blockade is evaluated by TOF (train-of-four ) as well as clinical observation. Our goal is to research and evaluate both agents in terms of complications and residual blockade. Materials and Methods: Our prospectively designed work included 100 cases operated under general anesthesia. demographic data, OF values, and complications were recorded. Results: A total of 100 patients, 63 neostigmine and 37 sugammedex, were consisted of in the search. The mean age of the sufferers was 41.9±16.9 years. When age was compared between the groups, it was found that the neostigmine (N) group was younger (p=0.027). There was a likeness between the groups in terms of surgical time, BMI (body mass index), Spo2, heart rate, mean arterial pressure, and total rocuronium consumption. The TOF value of the group N was 1(0.87-1), while that of the group sugamedex (S) was 1(0.91-1) and was found to be significant (p=0.045). There was no difference in TOF between cases who received an additional dose of rocuronium and those who did not receive an additional dose of rocuronium. Conclusions: As a result of the TOF values we obtained, we found that both agents were effective in removing the blockade, but the residual rate was statistically significantly lower in the sugamedex group, although not clinically significant. We did not encounter any complications in our study and we think that sugamedex is safer in terms of residual blockade.